Sulfate-reducing bacteria stimulate gut immune responses and contribute to inflammation in experimental colitis

Life Sciences

Volumn 189, Issue , 2017, Pages 29-38

  Figliuolo, Vanessa Ribeiro ^a,c   dos Santos, Liliane Martins ^b   Abalo, Alessandra ^c   Nanini, Hayandra ^a,c   Santos, Angela ^c   Brittes, Nilda M ^c   Bernardazzi, Claudio ^a   de Souza, Heitor Siffert Pereira ^a   Vieira, Leda Quercia ^b   Coutinho Silva, Robson ^a   Coutinho, Claudia Mara Lara Melo ^c,d  

^a FEDERAL UNIVERSITY OF RIO DE JANEIRO   (Brazil)

^b FEDERAL UNIVERSITY OF MINAS GERAIS   (Brazil)

^c INSTITUTO OSWALDO CRUZ   (Brazil)

^d FLUMINENSE FEDERAL UNIVERSITY   (Brazil)

Author keywords

Experimental colitis; Germ free mice; Inflammation; Mucosal immunity; Sulfate reducing bacteria

Indexed keywords

CD11B ANTIGEN; CD8 ANTIGEN; HYDROGEN SULFIDE; OXAZOLONE; TRINITROBENZENESULFONIC ACID; SULFATE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BACTERIAL COLONIZATION; CD8+ T LYMPHOCYTE; CELL ACTIVATION; CELL INFILTRATION; CELLULAR IMMUNITY; CONTROLLED STUDY; CYTOKINE PRODUCTION; DESULFOVIBRIO; DESULFOVIBRIO INDONESIENSIS; EXPERIMENTAL COLITIS; FEMALE; INTESTINE FLORA; LAMINA PROPRIA; MESENTERY LYMPH NODE; MOUSE; NONHUMAN; REGULATORY T LYMPHOCYTE; SULFATE REDUCING BACTERIA; TH17 CELL; WEIGHT REDUCTION; ANIMAL; C57BL MOUSE; COLITIS; DISEASE MODEL; HUMAN; IMMUNOLOGY; INFLAMMATION; METABOLISM; PATHOLOGY; TRANSGENIC MOUSE;

ANIMALS; COLITIS; DESULFOVIBRIO; DISEASE MODELS, ANIMAL; FEMALE; HUMANS; INFLAMMATION; MICE; MICE, INBRED C57BL; MICE, TRANSGENIC; OXAZOLONE; SULFATES; T-LYMPHOCYTES, REGULATORY; TH17 CELLS; TRINITROBENZENESULFONIC ACID; WEIGHT LOSS;

EID: 85029412653     PISSN: 00243205     EISSN: 18790631     Source Type: Journal    
DOI: 10.1016/j.lfs.2017.09.014     Document Type: Article

References (58)

1. Round, J.L., Mazmanian, S.K., The gut microbiota shapes intestinal immune responses during health and disease. Nat. Rev. Immunol. 9 (2009), 313–323.
2. Spasova, D.S., Surh, C.D., Blowing on embers: commensal microbiota and our immune system. Front. Immunol., 5, 2014, 318, 10.3389/fimmu.2014.00318 (eCollection).
3. Wang, S., Charbonnier, L.M., Noval, R.M., Georgiev, P., Li, N., Gerber, G., Bry, L., Chatila, T.A., MyD88 adaptor-dependent microbial sensing by regulatory T cells promotes mucosal tolerance and enforces commensalism. Immunity 43 (2015), 289–303.
4. Kubinak, J.L., Petersen, C., Stephens, W.Z., Soto, R., Bake, E., O'Connell, R.M., Round, J.L., MyD88 signaling in T cells directs IgA-mediated control of the microbiota to promote health. Cell Host Microbe 17 (2015), 153–163.
5. Forchielli, M.L., Walker, W.A., The role of gut-associated lymphoid tissues and mucosal defence. Br. J. Nutr. 93:Suppl. 1 (2005), S41–8.
6. Inagaki, H., Suzuki, T., Nomoto, K., Yoshikai, Y., Increased susceptibility to primary infection with Listeria monocytogenes in germfree mice may be due to lack of accumulation of L-selectin + CD44 + T cells in sites of inflammation. Infect. Immun. 64 (1996), 3280–3287.
7. Osawa, N., Mitsuhashi, S., Infection of germeree mice with Shigella flexneri 3a. Jpn. J. Exp. Med. 34 (1964), 77–80.
8. Ley, R.E., Backhed, F., Turnbaugh, P., Lozupone, C.A., Knight, R.D., Gordon, J.I., Obesity alters gut microbial ecology. Proc. Natl. Acad. Sci. U. S. A. 102 (2005), 11070–11075.
9. Ignacio, A., Morales, C.I., Camara, N.O., Almeida, R.R., Innate sensing of the gut microbiota: modulation of inflammatory and autoimmune diseases. Front. Immunol., 19(7), 2016, 54, 10.3389/fimmu.2016.00054 (eCollection).
10. Elinav, E., Strowig, T., Kau, A.L., Henao-Mejia, J., Thaiss, C.A., Booth, C.J., Peaper, D.R., Bertin, J., Eisenbarth, S.C., Gordon, J.I., Flavell, R.A., NLRP6 inflammasome regulates colonic microbial ecology and risk for colitis. Cell 145 (2011), 745–757.
11. Frank, D.N., Amand, A.L. St, Feldman, R.A., Boedeker, E.C., Harpaz, N., Pace, N.R., Molecular-phylogenetic characterization of microbial community imbalances in human inflammatory bowel diseases. Proc. Natl. Acad. Sci. U. S. A. 104 (2007), 13780–13785.
12. Targan, S.R., Murphy, L.K., Clarifying the causes of Crohn's. Nat. Med. 1 (1995), 1241–1243.
13. Swidsinski, A., Ladhoff, A., Pernthaler, A., Swidsinski, S., Loening-Baucke, V., Ortner, M., Weber, J., Hoffmann, U., Schreiber, S., Dietel, M., Lochs, H., Mucosal flora in inflammatory bowel disease. Gastroenterology 122 (2002), 44–54.
14. Barnich, N., Darfeuille-Michaud, A., Role of bacteria in the etiopathogenesis of inflammatory bowel disease. World J. Gastroenterol. 13 (2007), 5571–5576.
15. Rutgeerts, P., Hiele, M., Geboes, K., Peeters, M., Penninckx, F., Aerts, R., Kerremans, R., Controlled trial of metronidazole treatment for prevention of Crohn's recurrence after ileal resection. Gastroenterology 108 (1995), 1617–1621.
16. Rutgeerts, P., Goboes, K., Peeters, M., Hiele, M., Penninckx, F., Aerts, R., Kerremans, R., Vantrappen, G., Effect of faecal stream diversion on recurrence of Crohn's disease in the neoterminal ileum. Lancet 338 (1991), 771–774.
17. Gentschew, L., Ferguson, L.R., Role of nutrition and microbiota in susceptibility to inflammatory bowel diseases. Mol. Nutr. Food Res. 56 (2012), 524–535.
18. Onderdonk, A.B., Cisneros, R.L., Bronson, R.T., Enhancement of experimental ulcerative colitis by immunization with Bacteroides vulgatus. Infect. Immun. 42 (1983), 783–788.
19. Sellon, R.K., Tonkonogy, S., Schultz, M., Dieleman, L.A., Grenther, W., Balish, E., Rennick, D.M., Sartor, R.B., Resident enteric bacteria are necessary for development of spontaneous colitis and immune system activation in interleukin-10-deficient mice. Infect. Immun. 66 (1998), 5224–5231.
20. Eun, C.S., Mishima, Y., Wohlgemuth, S., Liu, B., Bower, M., Carroll, I.M., Sartor, R.B., Induction of bacterial antigen-specific colitis by a simplified human microbiota consortium in gnotobiotic interleukin-10 −/− mice. Infect. Immun. 82 (2014), 2239–2246.
21. Gibson, G.R., Macfarlane, G.T., Cummings, J.H., Occurrence of sulphate-reducing bacteria in human faeces and the relationship of dissimilatory sulphate reduction to methanogenesis in the large gut. J. Appl. Bacteriol. 65 (1988), 103–111.
22. Zinkevich, V., Beech, I.B., Screening of sulfate-reducing bacteria in colonoscopy samples from healthy and colitic human gut mucosa. FEMS Microbiol. Ecol. 34 (2000), 147–155.
23. Rowan, F., Docherty, N.G., Murphy, M., Murphy, T.B., Coffey, J.C., O'Connell, P.R., Bacterial colonization of colonic crypt mucous gel and disease activity in ulcerative colitis. Ann. Surg. 252 (2010), 869–875.
24. Roediger, W.E., Moore, J., Babidge, W., Colonic sulfide in pathogenesis and treatment of ulcerative colitis. Dig. Dis. Sci. 42 (1997), 1571–1579.
25. Ijssennagger, N., van der Meer, R., van Mil, S.W., Sulfide as a mucus barrier-breaker in inflammatory bowel disease?. Trends Mol. Med. 22 (2016), 190–199.
26. Ijssennagger, N., Belzer, C., Hooiveld, G.J., Dekker, J., van Mil, S.W., Muller, M., Kleerebezem, M., van der Meer, R., Gut microbiota facilitates dietary heme-induced epithelial hyperproliferation by opening the mucus barrier in colon. Proc. Natl. Acad. Sci. U. S. A. 112 (2015), 10038–10043.
27. Carter, R.N., Morton, N.M., Cysteine and hydrogen sulphide in the regulation of metabolism: insights from genetics and pharmacology. J. Pathol. 238 (2016), 321–332.
28. Martin, G.R., McKnight, G.W., Dicay, M.S., Coffin, C.S., Ferraz, J.G., Wallace, J.L., Hydrogen sulphide synthesis in the rat and mouse gastrointestinal tract. Dig. Liver Dis. 42 (2010), 103–109.
29. Qiu, X., Villalta, J., Lin, G., Lue, T.F., Role of hydrogen sulfide in the physiology of penile erection. J. Androl. 33 (2012), 529–535.
30. Yang, R., Qu, C., Zhou, Y., Konkel, J.E., Shi, S., Liu, Y., Chen, C., Liu, S., Liu, D., Chen, Y., Zandi, E., Chen, W., Zhou, Y., Shi, S., Hydrogen sulfide promotes Tet1- and Tet2-mediated Foxp3 demethylation to drive regulatory T cell differentiation and maintain immune homeostasis. Immunity 43 (2015), 251–263.
31. Pitcher, M.C., Beatty, E.R., Cummings, J.H., The contribution of sulphate reducing bacteria and 5-aminosalicylic acid to faecal sulphide in patients with ulcerative colitis. Gut 46 (2000), 64–72.
32. Deplancke, B., Gaskins, H.R., Hydrogen sulfide induces serum-independent cell cycle entry in nontransformed rat intestinal epithelial cells. FASEB J. 17 (2003), 1310–1312.
33. Moore, J.W., Babidge, W., Millard, S., Roediger, W.E., Effect of sulphide on short chain acyl-CoA metabolism in rat colonocytes. Gut 41 (1997), 77–81.
34. Pitcher, M.C., Beatty, E.R., Harris, R.M., Waring, R.H., Cummings, J.H., Sulfur metabolism in ulcerative colitis: investigation of detoxification enzymes in peripheral blood. Dig. Dis. Sci. 43 (1998), 2080–2085.
35. Dal-Secco, D., Cunha, T.M., Freitas, A., Alves-Filho, J.C., Souto, F.O., Fukada, S.Y., Grespan, R., Alencar, N.M., Neto, A.F., Rossi, M.A., Ferreira, S.H., Hothersall, J.S., Cunha, F.Q., Hydrogen sulfide augments neutrophil migration through enhancement of adhesion molecule expression and prevention of CXCR2 internalization: role of ATP-sensitive potassium channels. J. Immunol. 181 (2008), 4287–4298.
36. Miller, T.W., Wang, E.A., Gould, S., Stein, E.V., Kaur, S., Lim, L., Amarnath, S., Fowler, D.H., Roberts, D.D., Hydrogen sulfide is an endogenous potentiator of T cell activation. J. Biol. Chem. 287 (2012), 4211–4221.
37. Pleasants, J.R., Gnotobiotics. Melby, E.C. Jr., Altman, N.H., (eds.) Handbook of Laboratory Animal Science, 1974, CRV Press, Cleveland.
38. Feio, M.J., Beech, I.B., Carepo, M., Lopes, J.M., Cheung, C.W., Franco, R., Guezennec, J., Smith, J.R., Mitchell, J.I., Moura, J.J., Lino, A.R., Isolation and characterisation of a novel sulphate-reducing bacterium of the Desulfovibrio genus. Anaerobe 4 (1998), 117–130.
39. Wirtz, S., Neufert, C., Weigmann, B., Neurath, M.F., Chemically induced mouse models of intestinal inflammation. Nat. Protoc. 2 (2007), 541–546.
40. Dutra, R.C., Claudino, R.F., Bento, A.F., Marcon, R., Schmidt, E.C., Bouzon, Z.L., Pianowski, L.F., Calixto, J.B., Preventive and therapeutic euphol treatment attenuates experimental colitis in mice. PLoS One, 6, 2011, e27122.
41. Neves, A.R., Castelo-Branco, M.T., Figliuolo, V.R., Bernardazzi, C., Buongusto, F., Yoshimoto, A., Nanini, H.F., Coutinho, C.M., Carneiro, A.J., Coutinho-Silva, R., de Souza, H.S., Overexpression of ATP-activated P2X7 receptors in the intestinal mucosa is implicated in the pathogenesis of Crohn's disease. Inflamm. Bowel Dis. 20 (2014), 444–457.
42. Jacobs, M.B., Braverman, M.M., Hochneiser, S., Ultramicro-determination of sulfides in air. Anal. Chem. 29 (1957), 1349–1351.
43. Asseman, C., Powrie, F., Interleukin 10 is a growth factor for a population of regulatory T cells. Gut 42 (1998), 157–158.
44. Kamdar, K., Khakpour, S., Chen, J., Leone, V., Brulc, J., Mangatu, T., Antonopoulos, D.A., Chang, E.B., Kahn, S.A., Kirschner, B.S., Young, G., DePaolo, R.W., Genetic and metabolic signals during acute enteric bacterial infection alter the microbiota and drive progression to chronic inflammatory disease. Cell Host Microbe 19 (2016), 21–31.
45. Lin, C.S., Chang, C.J., Lu, C.C., Martel, J., Ojcius, D.M., Ko, Y.F., Young, J.D., Lai, H.C., Impact of the gut microbiota, prebiotics, and probiotics on human health and disease. Biom. J. 37 (2014), 259–268.
46. Schey, R., Danzer, C., Mattner, J., Perturbations of mucosal homeostasis through interactions of intestinal microbes with myeloid cells. Immunobiology 220 (2015), 227–235.
47. Garcia-Lafuente, A., Antolin, M., Guarner, F., Crespo, E., Salas, A., Forcada, P., Laguarda, M., Gavalda, J., Baena, J.A., Vilaseca, J., Malagelada, J.R., Incrimination of anaerobic bacteria in the induction of experimental colitis. Am. J. Phys. 272 (1997), G10–G15.
48. Atarashi, K., Tanoue, T., Shima, T., Imaoka, A., Kuwahara, T., Momose, Y., Cheng, G., Yamasaki, S., Saito, T., Ohba, Y., Taniguchi, T., Takeda, K., Hori, S., Ivanov, I.I., Umesaki, Y., Itoh, K., Honda, K., Induction of colonic regulatory T cells by indigenous Clostridium species. Science 331 (2011), 337–341.
49. de Waal, M.R., Yssel, H., de Vries, J.E., Direct effects of IL-10 on subsets of human CD4 + T cell clones and resting T cells. Specific inhibition of IL-2 production and proliferation. J. Immunol. 150 (1993), 4754–4765.
50. Takahashi, T., Kuniyasu, Y., Toda, M., Sakaguchi, N., Itoh, M., Iwata, M., Shimizu, J., Sakaguchi, S., Immunologic self-tolerance maintained by CD25 + CD4 + naturally anergic and suppressive T cells: induction of autoimmune disease by breaking their anergic/suppressive state. Int. Immunol. 10 (1998), 1969–1980.
51. Mann, N.S., Rossaro, L., Sudden infant death syndrome: the colon connection. Med. Hypotheses 66 (2006), 375–379.
52. Bhatia, M., Wong, F.L., Fu, D., Lau, H.Y., Moochhala, S.M., Moore, P.K., Role of hydrogen sulfide in acute pancreatitis and associated lung injury. FASEB J. 19 (2005), 623–625.
53. Yan, Y., Chen, C., Zhou, H., Gao, H., Chen, L., Chen, L., Gao, L., Zhao, R., Sun, Y., Endogenous hydrogen sulfide formation mediates the liver damage in endotoxemic rats. Res. Vet. Sci. 94 (2013), 590–595.
54. Weisiger, R.A., Pinkus, L.M., Jakoby, W.B., Thiol S-methyltransferase: suggested role in detoxication of intestinal hydrogen sulfide. Biochem. Pharmacol. 29 (1980), 2885–2887.
55. Linden, D.R., Furne, J., Stoltz, G.J., Abdel-Rehim, M.S., Levitt, M.D., Szurszewski, J.H., Sulphide quinone reductase contributes to hydrogen sulphide metabolism in murine peripheral tissues but not in the CNS. Br. J. Pharmacol. 165 (2012), 2178–2190.
56. Farkas, A.M., Panea, C., Goto, Y., Nakato, G., Galan-Diez, M., Narushima, S., Honda, K., Ivanov, I.I., Induction of Th17 cells by segmented filamentous bacteria in the murine intestine. J. Immunol. Methods 421 (2015), 104–111, 10.1016/j.jim.2015.03.020 (Epub; Apr 7).
57. Atarashi, K., Tanoue, T., Umesaki, Y., Honda, K., Regulation of Th17 cell differentiation by intestinal commensal bacteria. Benefic. Microbes 1 (2010), 327–334.
58. Jiang, W., Su, J., Zhang, X., Cheng, X., Zhou, J., Shi, R., Zhang, H., Elevated levels of Th17 cells and Th17-related cytokines are associated with disease activity in patients with inflammatory bowel disease. Inflamm. Res. 63 (2014), 943–950.